Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +6.56% | 0.00% | +5.41% |
Jun. 07 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
May. 29 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
John Doyle
DFI | Director of Finance/CFO | 46 | 23-04-30 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-10 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 19-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 19-02-28 |
Brett Monia
BRD | Director/Board Member | 62 | 20-09-30 |
Ellen Richstone
BRD | Director/Board Member | 72 | 21-10-31 |
Jack Khattar
CHM | Chairman | 62 | 19-12-31 |
Peggy Wallace
BRD | Director/Board Member | 67 | 16-08-31 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 40,058,498 | 38,448,014 ( 95.98 %) | 0 | 95.98 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.41% | 78.11M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.76% | 22.78B | |
-10.70% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- CGTX Stock
- Company Cognition Therapeutics, Inc.